Participants 141 191 4
patients with advanced chronic heart failure (CHF)
Participants 324 341 4
patients with CHF
Participants 374 537 6
23 patients in NYHA class II and III (20 men, three women, mean age 59+/-9 years) with stable CHF secondary to ischaemic heart disease [ejection fraction 37+/-7%],
Participants 658 731 3
oral CoQ(10) (100 mg tid), CoQ(10) plus supervised exercise training (ET)
